Literature DB >> 16678520

Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy.

Yumiko Ojima1, Akitaka Tsujikawa, Atsushi Otani, Yasuhiko Hirami, Hiroko Aikawa, Nagahisa Yoshimura.   

Abstract

PURPOSE: To report a case of recurrent bleeding after photodynamic therapy (PDT) in an eye with polypoidal choroidal vasculopathy (PCV).
DESIGN: Interventional case report.
METHODS: A 73-year-old man was treated in the left eye for PCV with PDT.
RESULTS: Two weeks after PDT, his left eye showed extensive subretinal hemorrhage, with a slight vision loss. Three months after PDT, subretinal hemorrhage was almost absorbed. He received a second session of PDT to the remaining choroidal neovascularization. Two weeks thereafter, his left eye showed massive suprachoroidal hemorrhage with further vision loss. One month after the second PDT, visual acuity was decreased to no light perception as a result of massive vitreous hemorrhage. Although the patient underwent pars plana vitrectomy, visual acuity in the left eye remained hand motion as a result of massive suprachoroidal hemorrhage.
CONCLUSIONS: Ophthalmologists and patients should be aware of the risk of massive bleeding after PDT in eyes with PCV.

Entities:  

Mesh:

Year:  2006        PMID: 16678520     DOI: 10.1016/j.ajo.2005.12.002

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

1.  Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy.

Authors:  Ryusaburo Mori; Mitsuko Yuzawa; Zeon Lee; Miho Haruyama; Eriko Akaza
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-30       Impact factor: 3.117

2.  Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.

Authors:  Masayuki Hata; Akitaka Tsujikawa; Masahiro Miyake; Kenji Yamashiro; Sotaro Ooto; Akio Oishi; Isao Nakata; Ayako Takahashi; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-30       Impact factor: 3.117

3.  Proteolytic Degradation and Inflammation Play Critical Roles in Polypoidal Choroidal Vasculopathy.

Authors:  Sandeep Kumar; Hiroyuki Nakashizuka; Alex Jones; Alyssia Lambert; Xuchen Zhao; Megan Shen; Mackenzie Parker; Shixian Wang; Zachary Berriochoa; Amrita Fnu; Stephanie VanBeuge; Patricia Chévez-Barrios; Mark Tso; Jon Rainier; Yingbin Fu
Journal:  Am J Pathol       Date:  2017-09-21       Impact factor: 4.307

Review 4.  Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.

Authors:  Yamini Sahu; Niharika Chaudhary; Mukesh Joshi; Aastha Gandhi
Journal:  Int Ophthalmol       Date:  2020-10-20       Impact factor: 2.031

5.  Prevalence and treatment patterns of ranibizumab and photodynamic therapy in a tertiary care setting in Malaysia.

Authors:  Nur Afiqah Mohamad; Vasudevan Ramachandran; Patimah Ismail; Hazlita Mohd Isa; Yoke Mun Chan; Nor Fariza Ngah; Norshakimah Md Bakri; Siew Mooi Ching; Fan Kee Hoo; Wan Aliaa Wan Sulaiman
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

6.  Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhage.

Authors:  H-C Lin; C-H Yang; C-M Yang
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

7.  Histopathology of Age-Related Macular Degeneration and Implications for Pathogenesis and Therapy.

Authors:  Ru-Ik Chee; Abdallah Mahrous; Lisa Koenig; Lindsay Skye Mandel; Fahd Yazdanie; Chi-Chao Chan; Mrinali P Gupta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Meta-analysis of best corrected visual acuity after treatment for myopic choroidal neovascularisation.

Authors:  Lin Zhou; Yi-Qiao Xing; Tuo Li; Yin Li; Xiu-Sheng Song; Jia-Zhang Li
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

9.  Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year.

Authors:  Tetsuo Ogino; Muneyasu Takeda; Hiroko Imaizumi; Utako Okushiba
Journal:  Jpn J Ophthalmol       Date:  2007-06-07       Impact factor: 2.447

Review 10.  Verteporfin PDT for non-standard indications--a review of current literature.

Authors:  Wai Man Chan; Tock-Han Lim; Alfredo Pece; Rufino Silva; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.